IBM and Inclusive Brains Partner on AI Brain-Machine Interface Tech

IBM and Inclusive Brains have announced a groundbreaking partnership to advance AI brain-machine interfaces (BMIs) through innovative AI and quantum machine learning techniques. This collaboration aims to enhance the functionality of BMIs, offering new possibilities for individuals with disabilities to interact with connected devices and digital environments without the need for traditional input methods like keyboards or voice commands.

The joint study between IBM and Inclusive Brains will focus on improving the performance of multimodal brain-machine interfaces, which have the potential to transform how people with disabilities engage with technology. By leveraging AI and quantum computing, the partnership seeks to develop more accurate and personalized BMIs that adapt to each user's unique needs and abilities.

Enhancing Accessibility through AI and Quantum Technology

Inclusive Brains' mission is to create technology that adapts in real-time to the physical and cognitive characteristics of each user, providing personalized assistance that supports decision-making, optimizes performance, and preserves mental and physical health. The company's multimodal cognitive agents are designed to detect variations in stress, attention, cognitive load, and fatigue levels in real-time, offering a more intuitive and responsive user experience.

Through the partnership, IBM's AI and quantum technologies will be used to enhance the accuracy of brain activity classification, enabling more precise and effective BMIs. This collaboration aligns with both companies' principles of responsible technology, including ethical considerations and recommendations for the responsible use of neurotechnology and neural data.

Broader Societal Benefits

Beyond improving accessibility for individuals with disabilities, the partnership between IBM and Inclusive Brains is expected to deliver broader societal benefits. By enhancing the understanding of brain activity patterns, the technology developed through this collaboration could contribute to the prevention of physical and mental health issues in the general population. This has the potential to revolutionize healthcare by providing new tools for early detection and intervention.

Béatrice Kosowski, President of IBM France, expressed pride in the collaboration, stating, "IBM is committed to supporting innovative startups like Inclusive Brains in developing technology that advances healthcare for the general population. By providing access to our AI and quantum technologies in a responsible manner, we aim to make a meaningful impact on society."

Inclusive Brains' Innovative Approach

Inclusive Brains has already achieved several milestones in developing non-invasive brain-machine interfaces. The company's Prometheus BCI, a multimodal interface, has enabled groundbreaking demonstrations such as a mind-controlled arm exoskeleton showcased at the Olympic Torch Relay, a mind-written tweet exchange with President Macron, and a mind-written parliamentary amendment.

Professor Olivier Oullier, CEO and Co-Founder of Inclusive Brains, highlighted the significance of the joint study with IBM, stating, "This collaboration will help us develop technology for personalized interactions between machines and their users, ultimately improving the quality of life for individuals with disabilities and beyond."

About IBM

IBM is a global leader in technology, offering solutions that help clients capitalize on insights from their data, streamline business processes, reduce costs, and gain a competitive edge. The company's innovations in AI, quantum computing, and consulting deliver open and flexible options backed by a commitment to trust, transparency, responsibility, inclusivity, and service.

This partnership with Inclusive Brains is part of IBM's ongoing efforts to drive innovation in healthcare and accessibility, leveraging its expertise in AI and quantum technologies to create solutions that improve lives and advance society.